Indrayani Biotech News
News
0
Ticker
526445.BO
ISIN
INE007C01021
Actualités Eulerpool Indrayani Biotech
Actualités de l'action Indrayani Biotech
Indrayani Biotech est suivi par de nombreux journalistes et investisseurs dans le monde. Nous rassemblons ici les dernières actualités concernant Indrayani Biotech.
Communiqués de presse relatifs à l'action Indrayani Biotech
Indrayani Biotech publie régulièrement sur son site web des communiqués pertinents pour les investisseurs.
Indrayani Biotech News 2026
Cette page contient toutes les actualités actuelles, analyses et communiqués de presse pour l'action Indrayani Biotech (526445.BO, ISIN : INE007C01021). Cela inclut les actualités Eulerpool, les analyses d'entreprise et les communiqués de presse officiels. Les données sont mises à jour régulièrement pour fournir aux investisseurs un aperçu complet des derniers développements chez Indrayani Biotech.
Indrayani Biotech Action
Indrayani Biotech Indrayani Biotech Ltd generates revenue through its diverse operational divisions, with the Food & Hospitality division supplying food services on a contract basis to colleges and universities, hospitals and healthcare institutions, corporate offices, industries, and information technology companies. The Engineering division contributes by offering solutions for design, development, manufacture, maintenance, and services in power electronics. The Healthcare division serves patients through single specialty clinics and hospitals, as well as outsourced single specialty departments within multi-specialty hospitals. Additionally, the Infrastructure division engages in real estate and infrastructure development. The Agri division markets and sells products such as organic milk, edible oil, vermi compost, and panchakavya, while the Biotech division focuses on marketing and selling microorganism-based bio fertilizer and bio control. These combined activities allow the Chennai-based company to serve a wide range of clients across engineering, food supply, healthcare, infrastructure, agriculture, and biotechnology sectors.